SLG
73
-4
HUM
52
10
NFLX
59
-2
MMC
55
-9
AFL
56
-4
NSC
51
3
GLW
53
-4
CAT
62
-4
F
64
10
UHS
51
-3
SRE
32
-6
SE
44
-5
BRK.B
38
4
PSA
43
-12
SHW
58
-3
HSIC
47
7
OKE
71
6
BMY
45
8
QCOM
66
-6
RL
59
-14
SLG
73
-4
HUM
52
10
NFLX
59
-2
MMC
55
-9
AFL
56
-4
NSC
51
3
GLW
53
-4
CAT
62
-4
F
64
10
UHS
51
-3
SRE
32
-6
SE
44
-5
BRK.B
38
4
PSA
43
-12
SHW
58
-3
HSIC
47
7
OKE
71
6
BMY
45
8
QCOM
66
-6
RL
59
-14
Financhill
Back

NuCana PLC Vs. Adaptimmune Therapeutics PLC Industry Stock Comparison

Sell
42

NCNA
NuCana PLC

Last Price:
2.65
Seasonality Move:
-12.75%
Sell
48

ADAP
Adaptimmune Therapeutics PLC

Last Price:
1.05
Seasonality Move:
-8.14%
Sell
42
NuCana PLC (NCNA) is a Sell

Is NuCana PLC a Buy, Sell or Hold?

  • The current NuCana PLC [NCNA] share price is $2.77. The Score for NCNA is 42, which is 16% below its historic median score of 50, and infers higher risk than normal.
  • NCNA is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
48
Adaptimmune Therapeutics PLC (ADAP) is a Sell

Is Adaptimmune Therapeutics PLC a Buy, Sell or Hold?

  • The current Adaptimmune Therapeutics PLC [ADAP] share price is $1.05. The Score for ADAP is 48, which is 4% below its historic median score of 50, and infers higher risk than normal.
  • ADAP is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.

NCNA Stock Price Chart

What is NuCana PLC's stock price today?

  • The NuCana PLC share price today is $2.77
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NCNA is experiencing buying pressure, which is a positive indicator for future bullish movement.

ADAP Stock Price Chart

What is Adaptimmune Therapeutics PLC's stock price today?

  • The Adaptimmune Therapeutics PLC share price today is $1.05
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and ADAP is experiencing buying pressure, which is a positive indicator for future bullish movement.

NCNA Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.27 Sell
Relative Strength Index (14 RSI): 34.51 Sell
Chaikin Money Flow: 5001 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (2.81 - 3.45) Sell
Bollinger Bands (100): (3.18 - 7.68) Sell

ADAP Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 55.32 Buy
Chaikin Money Flow: 1054324 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.91 - 1.07) Buy
Bollinger Bands (100): (0.99 - 1.45) Sell

NCNA Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 2.8 Sell
20-day SMA: 3.02 Sell
50-day SMA: 3.46 Sell
200-day SMA: 8.19 Sell
8-day EMA: 2.79 Sell
20-day EMA: 3.01 Sell
50-day EMA: 3.74 Sell
200-day EMA: 8.6 Sell

ADAP Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.92 Buy
20-day SMA: 0.98 Buy
50-day SMA: 1.05 Sell
200-day SMA: 0.94 Buy
8-day EMA: 0.95 Buy
20-day EMA: 0.97 Buy
50-day EMA: 1.05 Buy
200-day EMA: 1.07 Sell

NuCana PLC Earnings Growth & NCNA Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.84 per share, an increase next quarter of $0.09 per share, an increase this year of $2.64 per share, and a decrease next year of $3.67 per share.

Adaptimmune Therapeutics PLC Earnings Growth & ADAP Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.01 per share, and a decrease next year of $0.17 per share.

NuCana PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Adaptimmune Therapeutics PLC Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):